Cargando…

Postprandial Lipoproteins and Cardiovascular Disease Risk in Diabetes Mellitus

Diabetes mellitus is associated with increased risk for atherosclerotic cardiovascular disease (CVD). Recent prospective studies in healthy individuals suggest that the postprandial triglyceride (TG) level is a better independent predictor for assessing future CVD events than fasting TG levels. In c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Enkhmaa, Byambaa, Ozturk, Zeynep, Anuurad, Erdembileg, Berglund, Lars
Formato:	Texto
Lenguaje:	English
Publicado:	Current Science Inc. 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821507/ https://www.ncbi.nlm.nih.gov/pubmed/20425069 http://dx.doi.org/10.1007/s11892-009-0088-4

Ejemplares similares

COVID-19 and public health efforts in Mongolia: A lesson maybe learned?
por: Bayasgalan, Tumenbayar, et al.
Publicado: (2020)

SUN-580 PCSK9 and Lp(a): Association Between PCSK9 Level and Larger Apo(a) Isoform Size in African-Americans and Caucasians
por: Byambaa, Enkhmaa, et al.
Publicado: (2020)

PCSK9 in African Americans and Caucasians in Relation to Lp(a) Level, Apo(a) Size and Heritability
por: Enkhmaa, Byambaa, et al.
Publicado: (2020)

Lp(a)‐Associated Oxidized Phospholipids in Healthy Black and White Participants in Relation to apo(a) Size, Age, and Family Structure
por: Berglund, Lars, et al.
Publicado: (2021)

Attenuated Age-Impact on Systemic Inflammatory Markers in the Presence of a Metabolic Burden
por: Anuurad, Erdembileg, et al.
Publicado: (2015)

Non-genetic influences on lipoprotein(a) concentrations
por: Enkhmaa, Byambaa, et al.
Publicado: (2022)

Lipoprotein(a) and diet—a challenge for a role of saturated fat in cardiovascular disease risk reduction?
por: Law, Hayley G., et al.
Publicado: (2023)

Non-HDL-C levels and residual cardiovascular risk: Do population-specific precision approaches offer advantages?
por: Enkhmaa, Byambaa, et al.
Publicado: (2018)

Diet and Lp(a): Does Dietary Change Modify Residual Cardiovascular Risk Conferred by Lp(a)?
por: Enkhmaa, Byambaa, et al.
Publicado: (2020)

Statins and Lp(a) – the plot thickens
por: Enkhmaa, Byambaa, et al.
Publicado: (2019)

Building an institutional K awardee program at UC Davis through utilization of CTSA resources
por: Guo, Betty P., et al.
Publicado: (2021)

Food Insecurity and Cardiovascular Disease Risk Factors among Mississippi Adults
por: Mendy, Vincent L., et al.
Publicado: (2018)

Cardiovascular Disease Mortality in Mississippi, 2000–2018
por: Mendy, Vincent L., et al.
Publicado: (2022)

Postprandial Hyperlipidemia and Remnant Lipoproteins
por: Masuda, Daisaku, et al.
Publicado: (2017)

Feasibility of postprandial optical scattering of lipoproteins in blood as an optical marker of cardiovascular disease risk: modeling and experimental validation
por: Pilvar, Anahita, et al.
Publicado: (2023)

Are diabetes mellitus and lipoprotein(a) independently or causally associated with an increased cardiovascular risk?
por: Vavlukis, Marija
Publicado: (2017)

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk
por: Aryangat, Ajikumar V, et al.
Publicado: (2010)

Postprandial Dyslipidemia: Pathophysiology and Cardiovascular Disease Risk Assessment
por: Higgins, Victoria, et al.
Publicado: (2017)

Reducing saturated fat intake lowers LDL-C but increases Lp(a) levels in African Americans: the GET-READI feeding trial
por: Law, Hayley G., et al.
Publicado: (2023)

Postprandial Glucose Spikes, an Important Contributor to Cardiovascular Disease in Diabetes?
por: Hanssen, Nordin M. J., et al.
Publicado: (2020)

Postprandial changes of lipoprotein profile: effect of abdominal obesity
por: Sabaka, Peter, et al.
Publicado: (2013)

Fasting remnant lipoproteins can predict postprandial hyperlipidemia
por: Nagata, Tomoki, et al.
Publicado: (2012)

Lipoprotein(a): a not-so-well-known risk factor for the development of cardiovascular disease in patients with type 2 diabetes mellitus
por: Moon, Min Kyong
Publicado: (2016)

Low fasting low high-density lipoprotein and postprandial lipemia
por: Kolovou, Genovefa D, et al.
Publicado: (2004)

Correction: fasting remnant lipoproteins can predict postprandial hyperlipidemia
por: Nagata, Tomoki, et al.
Publicado: (2014)

Postprandial insulin resistance as an early predictor of cardiovascular risk
por: Lautt, W Wayne
Publicado: (2007)

Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus
por: Kim, Ji-Hye, et al.
Publicado: (2011)

Postprandial lipoprotein profile in two modes of high-intensity intermittent exercise
por: Panissa, Valéria Leme Gonçalves, et al.
Publicado: (2016)

Postprandial hyperglycemia and postprandial hypertriglyceridemia in type 2 diabetes
por: Hiyoshi, Toru, et al.
Publicado: (2019)

Fasting and postprandial lipid parameters: A comparative evaluation of cardiovascular risk assessment in prediabetes and diabetes
por: Chakraborty, Montosh, et al.
Publicado: (2020)

Comparative study on fasting and postprandial lipid profile in type 2 diabetes mellitus
por: Chahal, Jasmeen, et al.
Publicado: (2021)

Effect of sleeve gastrectomy on postprandial lipoprotein metabolism in morbidly obese patients
por: Waldmann, Elisa, et al.
Publicado: (2013)

Lipoprotein-Associated Oxidative Stress: A New Twist to the Postprandial Hypothesis
por: Le, Ngoc-Anh
Publicado: (2014)

Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins
por: Ansar, Sameer, et al.
Publicado: (2011)

Study of Postprandial Lipaemia in Type 2 Diabetes Mellitus: Exenatide versus Liraglutide
por: Voukali, Maria, et al.
Publicado: (2014)

Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus
por: Torimoto, Keiichi, et al.
Publicado: (2015)

Postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk
por: DiNicolantonio, James J, et al.
Publicado: (2017)

Diabetes Mellitus and Cardiovascular Disease
por: Aganovic, Izet
Publicado: (2003)

Comparison of on-Statin Lipid and Lipoprotein Levels for the Prediction of First Cardiovascular Event in Type 2 Diabetes Mellitus
por: Kim, Ji Yoon, et al.
Publicado: (2023)

Role of Different Low-Density Lipoprotein-Lowering Medications on Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients With Diabetes Mellitus
por: Saag, Jordan L, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dkpirigdf6ptt101dqn1ub01g7